ArticleLeukemia2020
Dasatinib overcomes stroma-based resistance to the FLT3 inhibitor quizartinib using multiple mechanisms.
Ami B Patel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ArticleLeukemia2020
Ami B Patel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.